| 注册
首页|期刊导航|中国当代医药|肺泡灌洗液靶向二代测序技术检测在疑似肺结核患者的诊断价值

肺泡灌洗液靶向二代测序技术检测在疑似肺结核患者的诊断价值

史传见 郭勇 韩晓娟 任翠竹 居马汗·阿迪力

中国当代医药2026,Vol.33Issue(11):47-51,5.
中国当代医药2026,Vol.33Issue(11):47-51,5.DOI:10.3969/j.issn.1674-4721.2026.11.09

肺泡灌洗液靶向二代测序技术检测在疑似肺结核患者的诊断价值

Diagnostic value of bronchoalveolar lavage fluid targeted next-generation sequencing testing in patients with suspected pulmonary tuberculosis

史传见 1郭勇 1韩晓娟 1任翠竹 1居马汗·阿迪力1

作者信息

  • 1. 新疆维吾尔自治区哈密市中心医院感染科,新疆哈密 839000
  • 折叠

摘要

Abstract

Objective To investigate the early diagnostic value of bronchoalveolar lavage fluid Targeted next-generation se-quencing(tNGS)testing in patients with suspected pulmonary tuberculosis(PTB).Methods A total of 320 patients with sus-pected PTB admitted to Hami Central Hospital from April 2024 to February 2025 were selected as study subjects.All patients underwent tNGS testing,Xpert testing,sputum smear testing,and Mycobacterium tuberculosis(MTB)culture testing on bronchoalveolar lavage fluid.The diagnostic efficacy of the four testing methods for PTB were compared using the clinical diagnosis results as the reference standard.Results Among the 320 patients with suspected PTB,175 were confirmed as PTB and 145 as non-PTB.The Kappa values of tNGS of bronchoalveolar lavage fluid,Xpert MTB/RIF assay,sputum smear examination,and MTB culture were 0.875,0.772,0.335,and 0.478,respectively.The sensitivity of tNGS of bronchoalveolar lavage fluid was higher than that of Xpert MTB/RIF assay,sputum smear examination,and MTB culture,with statistically significant differences(P<0.001).Consistency analysis showed that tNGS had good consistency.Conclusion Bronchoalve-olar lavage fluid tNGS testing has good diagnostic performance for PTB,which can reduce the rate of missed diagnosis,promote early treatment,and interrupt the transmission chain.

关键词

肺泡灌洗液/靶向二代测序技术/肺结核/诊断价值

Key words

Bronchoalveolar lavage fluid/Targeted next-generation sequencing/Pulmonary tuberculosis/Diagnostic value

分类

医药卫生

引用本文复制引用

史传见,郭勇,韩晓娟,任翠竹,居马汗·阿迪力..肺泡灌洗液靶向二代测序技术检测在疑似肺结核患者的诊断价值[J].中国当代医药,2026,33(11):47-51,5.

基金项目

新疆维吾尔自治区哈密市名医培优工程创新科研项目(2024-HM-MYPY-008). (2024-HM-MYPY-008)

中国当代医药

1674-4721

访问量0
|
下载量0
段落导航相关论文